Next-Generation Trachea-Esophageal Organoids for Scalable Disease Modeling
A scalable, reproducible, and human-specific platform for modeling trachea-esophageal development and congenital malformations such as Esophageal Atresia (EA)/ Tracheoesophageal Fistula (TEF).
Innovative IGF-2 Receptor Agonists for Treating Neurodevelopmental Disorders and Neurodegenerative Diseases
Disease-modifying therapy with differentiated mechanisms of action to restore memory and motor function in neurodegenerative diseases and neurodevelopmental disorders.
Prognostic Tool for Risk Stratifying Patients with Epilepsy to Improve Clinical Outcomes
Earlier and more accurate method to diagnose and treat Status Epilepticus (SE) and New-Onset Refractory Status Epilepticus (NORSE).